- RNAC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Cartesian Therapeutics (RNAC) S-3Shelf registration
Filed: 6 Aug 20, 4:59pm
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Selecta Biosciences, Inc. for the registration of up to $200,000,000 of its common stock, preferred stock, debt securities, warrants, and units and of up to $50,000,000 of its common stock related to the Open Market Sale Agreement, and to the incorporation by reference therein of our report dated March 12, 2020, with respect to the consolidated financial statements of Selecta Biosciences, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2019, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP | |
Boston, Massachusetts | |
August 6, 2020 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.